Regent Pacific Group Limited (RPGLF)

Market Cap	28.07M
Revenue (ttm)	833.00K
Net Income (ttm)	-4.08M
Shares Out	n/a
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Average Volume	8,061
Open	0.1000
Previous Close	0.1000
Day's Range	0.1000 - 0.1000
52-Week Range	0.0007 - 0.1010
Beta	1.03
RSI	47.26
Earnings Date	Aug 26, 2025

About Regent Pacific Group

Regent Pacific Group Limited, an investment holding company, focuses on healthcare and life sciences sectors in Europe, the United States, and the Asia Pacific. The company operates through Biopharma and Corporate Investment segments. It is involved in the research, development, manufacturing, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of AI system for the field of biological aging clocks, at the molecular, cellular, tissue, organ, system, physiological, and psycholog...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 17
• Stock Exchange: OTCMKTS
• Ticker Symbol: RPGLF

Financial Performance

In 2024, Regent Pacific Group's revenue was $719,000, an increase of 147.08% compared to the previous year's $291,000. Losses were -$4.48 million, -82.11% less than in 2023.